US5525328A
(en)
*
|
1994-06-24 |
1996-06-11 |
Nanosystems L.L.C. |
Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging
|
EP0766663A1
(en)
*
|
1994-06-24 |
1997-04-09 |
NanoSystems L.L.C. |
2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
|
US5567410A
(en)
*
|
1994-06-24 |
1996-10-22 |
The General Hospital Corporation |
Composotions and methods for radiographic imaging
|
US5560932A
(en)
*
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
US5716642A
(en)
*
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
US5665331A
(en)
*
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
CA2213638C
(en)
*
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
CA2346001C
(en)
*
|
1998-10-01 |
2003-12-30 |
Elan Pharma International, Limited |
Controlled release nanoparticulate compositions
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
CN100444830C
(zh)
*
|
1998-11-02 |
2008-12-24 |
伊兰公司,Plc |
多颗粒改进释放组合物
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
GB9828103D0
(en)
*
|
1998-12-18 |
1999-02-17 |
Nycomed Imaging As |
Process
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
DE60203506T2
(de)
*
|
2001-06-22 |
2006-02-16 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
DE60217367T2
(de)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen enthaltend insulin
|
US6908626B2
(en)
|
2001-10-12 |
2005-06-21 |
Elan Pharma International Ltd. |
Compositions having a combination of immediate release and controlled release characteristics
|
US20030152519A1
(en)
*
|
2001-11-07 |
2003-08-14 |
Reinhard Koenig |
Methods for vascular imaging using nanoparticulate contrast agents
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
WO2003066021A2
(en)
|
2002-02-04 |
2003-08-14 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
血管新生抑制剤のナノ粒子組成物
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
ES2380318T3
(es)
|
2002-04-12 |
2012-05-10 |
Alkermes Pharma Ireland Limited |
Formulaciones nanoparticulares de megestrol
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
ATE419835T1
(de)
*
|
2002-05-06 |
2009-01-15 |
Elan Pharma Int Ltd |
Nystatin-nanopartikelzusammensetzungen
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
JP4533134B2
(ja)
*
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
ES2355723T3
(es)
*
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
JP4776233B2
(ja)
*
|
2002-11-12 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
摩損しにくくかつプルランを含む速崩壊性固形製剤
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
WO2004078162A1
(en)
*
|
2003-01-31 |
2004-09-16 |
Elan Pharma International Ltd. |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
WO2004105809A1
(en)
*
|
2003-05-22 |
2004-12-09 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
JP2007501839A
(ja)
*
|
2003-08-08 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
新規メタキサロン組成物
|
JP4787165B2
(ja)
*
|
2003-11-05 |
2011-10-05 |
エラン ファーマ インターナショナル,リミティド |
表面安定剤としてペプチドを有するナノ粒子組成物
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
BRPI0518187A
(pt)
*
|
2004-11-16 |
2008-11-04 |
Elan Pharma Int Ltd |
formulações de olanzapina em nanopartìcula injetáveis
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
AU2005316473B2
(en)
*
|
2004-12-15 |
2011-07-14 |
Elan Pharma International Ltd. |
Nanoparticulate tacrolimus formulations
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
US20060165806A1
(en)
*
|
2005-01-06 |
2006-07-27 |
Elan Pharma International Limited |
Nanoparticulate candesartan formulations
|
MX2007009915A
(es)
|
2005-02-15 |
2007-11-06 |
Elan Pharma Int Ltd |
Formulaciones en aerosol e inyectables de benzodiazepina nanoparticulada.
|
WO2006096462A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of heterocyclic amide derivatives
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
BRPI0606283A2
(pt)
*
|
2005-03-16 |
2009-06-09 |
Elan Pharma Int Ltd |
formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
|
WO2006102117A1
(en)
*
|
2005-03-17 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate biphosphonate compositions
|
MX2007011772A
(es)
*
|
2005-03-23 |
2007-12-05 |
Elan Pharma Int Ltd |
Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas.
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
WO2006110811A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate quinazoline derivative formulations
|
WO2006110802A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
US20090081297A1
(en)
*
|
2005-04-27 |
2009-03-26 |
Cook Robert O |
Use of surface tension reducing agents in aerosol formulations
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
AU2006336417A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel formulations
|
JP2008540691A
(ja)
*
|
2005-05-16 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
セファロスポリンを含むナノ粒子および放出制御組成物
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
KR20080017065A
(ko)
*
|
2005-06-03 |
2008-02-25 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 아세트아미노펜 제제
|
CN101232870A
(zh)
*
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
CA2612994A1
(en)
|
2005-06-08 |
2006-12-08 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cefditoren
|
WO2006135689A2
(en)
*
|
2005-06-09 |
2006-12-21 |
Elan Pharma International, Limited |
Nanoparticulate ebastine formulations
|
EP1898911A1
(en)
*
|
2005-06-13 |
2008-03-19 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
WO2006138421A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
US20070015719A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International Limited |
Nanoparticulate clarithromycin formulations
|
CA2622200A1
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
WO2007035348A2
(en)
|
2005-09-15 |
2007-03-29 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
EP2040675A1
(en)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoparticulate posaconazole formulations
|
WO2008008733A2
(en)
*
|
2006-07-10 |
2008-01-17 |
Elan Pharma International Ltd. |
Nanoparticulate sorafenib formulations
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
KR20110007095A
(ko)
*
|
2008-03-21 |
2011-01-21 |
엘란 파마 인터내셔널 리미티드 |
이마티니브의 부위-특이적 전달을 위한 조성물 및 사용방법
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
US20100316725A1
(en)
|
2009-05-27 |
2010-12-16 |
Elan Pharma International Ltd. |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
CN102497857A
(zh)
|
2009-06-19 |
2012-06-13 |
纳米模型匈牙利有限公司 |
纳米结构的西地那非碱、其药学可接受的盐和共结晶、它们的组合物、其制备方法和包含它们的药物组合物
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
JP6871919B2
(ja)
*
|
2015-06-16 |
2021-05-19 |
ナノファギックス エルエルシー |
薬物送達及びイメージング化学コンジュゲート、製剤及びその使用方法
|